http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021504418-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-76 |
| filingDate | 2018-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021504418-A |
| titleOfInvention | Method for producing 2- (5-methoxyisochroman-1-yl) -4,5-dihydro-1H-imidazole and its hydrogen sulfate |
| abstract | The present disclosure discloses alpha 2A adrenergic receptor agonists of isochroman structure, such as 2- (5-methoxyisochroman-1-yl) -4,5-dihydro-1H-imidazole (I) and sulfate (Ia). An improved method for the production of pharmaceutically acceptable salts, and a novel intermediate compound used in that method, namely N- (2-aminoethyl) -5-methoxyisochroman-1-carboxamide. Regarding hydrate (V). Alpha 2A agonists are useful for use as therapeutic, sedative or analgesic agents for anxiety, and for other disorders in which alpha 2A agonists are desired. |
| priorityDate | 2017-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.